UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis and Treatment of ADHD in the United States: Update by Gender and Race

Journal of attention disorders, 2020-01, Vol.24 (1), p.10-19

2020

Volltextzugriff (PDF)

All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Drug safety, 2018-02, Vol.41 (2), p.213-228

2018

Volltextzugriff (PDF)

Effectiveness of a pharmacist–nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care

American journal of health-system pharmacy, 2009-11, Vol.66 (22), p.2027-2031

2009

Volltextzugriff (PDF)

Combined Gabapentinoid and Opioid Use

Annals of internal medicine, 2019-06, Vol.170 (12), p.908

2019

Volltextzugriff (PDF)

Need for international classification of gabapentin as a controlled substance

BMJ (Online), 2018-11, p.k4978

2018

Volltextzugriff (PDF)

Economic Implications of Sleep Disorders

PharmacoEconomics, 2010-11, Vol.28 (11), p.1015-1023

2010

Volltextzugriff (PDF)

Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population

Clinical drug investigation, 2017-08, Vol.37 (8), p.763-773

2017

Volltextzugriff (PDF)

Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Drug safety, 2018-06, Vol.41 (6), p.643-644

2018

Volltextzugriff (PDF)

Use of Proton Pump Inhibitors for the Provision of Stress Ulcer Prophylaxis: Clinical and Economic Consequences

PharmacoEconomics, 2014, Vol.32 (1), p.5-13

2014

Volltextzugriff (PDF)

National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995

Clinical pediatrics, 1999-04, Vol.38 (4), p.209-217

1999

Volltextzugriff (PDF)

Cardiovascular Risk Factors and Provision of Lifestyle Counseling for Diabetes or Prediabetes With Comorbid Obesity: Analysis of Office-Based Physician Visits Made by Patients 20 Years of Age or Older

Diabetes spectrum, 2019-02, Vol.32 (1), p.53-59

2019

Volltextzugriff (PDF)

Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2018-02, Vol.18 (1), p.65-71

2018

Volltextzugriff (PDF)

Call for increased pharmacovigilance of gabapentin

BMJ (Online), 2017-11, p.j5456

2017

Volltextzugriff (PDF)

Financial Impact of Direct-Acting Oral Anticoagulants in Medicaid: Budgetary Assessment Based on Number Needed to Treat

Applied health economics and health policy, 2017-04, Vol.15 (2), p.203-214

2017

Volltextzugriff (PDF)

Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States

International clinical psychopharmacology, 2008-03, Vol.23 (2), p.106-109

2008

Volltextzugriff (PDF)

Diagnosis of Depression and Use of Antidepressant Pharmacotherapy Among Adults in the United States: Does a Disparity Persist by Ethnicity/Race?

Clinical drug investigation, 2012-02, Vol.32 (2), p.139-144

2012

Volltextzugriff (PDF)

Concomitant Use of Triptan, and SSRI or SNRI After the US Food and Drug Administration Alert on Serotonin Syndrome

Headache, 2012-02, Vol.52 (2), p.198-203

2012

Volltextzugriff (PDF)

Attention-Deficit/Hyperactivity Disorder Among Children and Adolescents in the United States: Trend in Diagnosis and Use of Pharmacotherapy by Gender

Clinical pediatrics, 2012-06, Vol.51 (6), p.584-589

2012

Volltextzugriff (PDF)

Concomitant Triptan and SSRI or SNRI Use: A Risk for Serotonin Syndrome

Headache, 2008-01, Vol.48 (1), p.126-129

2008

Volltextzugriff (PDF)

Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants

CNS drugs, 2002, Vol.16 (2), p.129-137

2002

Volltextzugriff (PDF)

Trends in ADHD and stimulant use among adults: 1995-2002

Psychiatric services (Washington, D.C.), 2005-12, Vol.56 (12)

2005

Volltextzugriff (PDF)

Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2010-01, Vol.10 (2), p.105-108

2010

Volltextzugriff (PDF)

The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid Population

Medical care, 1994-03, Vol.32 (3), p.214-226

1994

Volltextzugriff (PDF)

Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995–99

International clinical psychopharmacology, 2004-01, Vol.19 (1), p.17-22

2004

Volltextzugriff (PDF)

Datapoints: Trends in ADHD and Stimulant Use Among Adults: 1995-2002

Psychiatric services (Washington, D.C.), 2005-12, Vol.56 (12), p.1497-1497

2005

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnosis and Treatment of ADHD in the United States: Update by Gender and Race

All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Effectiveness of a pharmacist–nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care

Combined Gabapentinoid and Opioid Use

Need for international classification of gabapentin as a controlled substance

Economic Implications of Sleep Disorders

Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population

Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population

Use of Proton Pump Inhibitors for the Provision of Stress Ulcer Prophylaxis: Clinical and Economic Consequences

National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995

Cardiovascular Risk Factors and Provision of Lifestyle Counseling for Diabetes or Prediabetes With Comorbid Obesity: Analysis of Office-Based Physician Visits Made by Patients 20 Years of Age or Older

Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits

Call for increased pharmacovigilance of gabapentin

Financial Impact of Direct-Acting Oral Anticoagulants in Medicaid: Budgetary Assessment Based on Number Needed to Treat

Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States

Diagnosis of Depression and Use of Antidepressant Pharmacotherapy Among Adults in the United States: Does a Disparity Persist by Ethnicity/Race?

Concomitant Use of Triptan, and SSRI or SNRI After the US Food and Drug Administration Alert on Serotonin Syndrome

Attention-Deficit/Hyperactivity Disorder Among Children and Adolescents in the United States: Trend in Diagnosis and Use of Pharmacotherapy by Gender

Concomitant Triptan and SSRI or SNRI Use: A Risk for Serotonin Syndrome

Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants

Trends in ADHD and stimulant use among adults: 1995-2002

Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia

The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid Population

Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995–99

Datapoints: Trends in ADHD and Stimulant Use Among Adults: 1995-2002

Aktive Filter

Suchergebnisse filtern